• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • EnClear Spins out of QurAlis americanpharmaceuticalreview
    December 29, 2018
    EnClear Therapies has spun-out from QurAlis Corporation, a biotech company focused on developing precision therapeutics for ALS and other neurological diseases. EnClear’s mission is to halt the progression of ....
  • QurAlis Launches with Seed Funding from MPH, Amgen and Alexandria Venture americanpharmaceuticalreview
    April 09, 2018
    QurAlis announced the addition of biotech investors MP Healthcare Venture Management (MPH), Amgen Ventures, and Alexandria Venture Investments, who have joined to cure Amyotrophic Lateral Sclerosis (ALS)

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service